Trilogy Capital’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Buy
14,532
+92
+0.6% +$4.83K 0.03% 228
2026
Q1
$760K Hold
14,440
0.03% 217
2025
Q4
$679K Sell
14,440
-1,025
-7% -$48K 0.03% 222
2025
Q3
$726K Sell
15,465
-1,000
-6% -$48.4K 0.03% 207
2025
Q2
$804K Sell
16,465
-200
-1% -$9.7K 0.04% 192
2025
Q1
$866K Hold
16,665
0.05% 182
2024
Q4
$803K Hold
16,665
0.04% 184
2024
Q3
$785K Hold
16,665
0.04% 189
2024
Q2
$800K Buy
+16,665
New +$779K 0.04% 181
2018
Q2
Sell
-600
Closed -$28K 576
2018
Q1
$28K Buy
+600
New +$32.1K ﹤0.01% 202

Other funds holding AMLP

Trilogy Capital's AMLP Position: Q2 2026 in Review

Trilogy Capital increased its Alerian MLP ETF (AMLP) stake by 0.64% in Q2 2026, buying an estimated $4.83K and bringing the position to 14,532 shares worth $753K. The position accounts for 0.03% of the portfolio, ranked #228.

Trilogy Capital first reported a position in AMLP in Q1 2018 and has held it in 10 quarters since. The position peaked at $866K in Q1 2025. 807 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.

  • Trilogy Capital held 14,532 shares of Alerian MLP ETF worth $753K as of Q2 2026.
  • Trilogy Capital bought 92 Alerian MLP ETF shares in Q2 2026, an estimated $4.83K.
  • Alerian MLP ETF made up 0.03% of Trilogy Capital's portfolio in Q2 2026, its #228 holding.
  • Trilogy Capital first reported a position in Alerian MLP ETF in Q1 2018 and has held it in 10 quarters since.
  • Trilogy Capital's Alerian MLP ETF position peaked at $866K in Q1 2025.
  • 807 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.